CN105963575A - 一种治疗牛皮癣的中药制剂及制备方法 - Google Patents
一种治疗牛皮癣的中药制剂及制备方法 Download PDFInfo
- Publication number
- CN105963575A CN105963575A CN201610621975.5A CN201610621975A CN105963575A CN 105963575 A CN105963575 A CN 105963575A CN 201610621975 A CN201610621975 A CN 201610621975A CN 105963575 A CN105963575 A CN 105963575A
- Authority
- CN
- China
- Prior art keywords
- parts
- herba
- chinese medicine
- medicine preparation
- traditional chinese
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000003814 drug Substances 0.000 title claims abstract description 71
- 238000002360 preparation method Methods 0.000 title claims abstract description 64
- 201000004681 Psoriasis Diseases 0.000 title abstract description 14
- 238000011282 treatment Methods 0.000 claims abstract description 40
- 239000004615 ingredient Substances 0.000 claims abstract description 14
- 235000011201 Ginkgo Nutrition 0.000 claims abstract description 11
- 235000008100 Ginkgo biloba Nutrition 0.000 claims abstract description 11
- 241000576409 Ligustrum sinense Species 0.000 claims abstract description 9
- 241001643642 Viticis Species 0.000 claims abstract description 9
- 244000194101 Ginkgo biloba Species 0.000 claims abstract 2
- 239000002994 raw material Substances 0.000 claims description 13
- 210000000582 semen Anatomy 0.000 claims description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 12
- 239000000843 powder Substances 0.000 claims description 10
- 239000012153 distilled water Substances 0.000 claims description 9
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims description 9
- 241001164374 Calyx Species 0.000 claims description 8
- 244000025254 Cannabis sativa Species 0.000 claims description 8
- 241000531495 Corydalis edulis Species 0.000 claims description 8
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 8
- 208000002474 Tinea Diseases 0.000 claims description 6
- 241000130764 Tinea Species 0.000 claims description 6
- 239000000706 filtrate Substances 0.000 claims description 6
- 239000000203 mixture Substances 0.000 claims description 5
- 238000010438 heat treatment Methods 0.000 claims description 4
- 238000000034 method Methods 0.000 claims description 4
- -1 boil 2~3 hours Substances 0.000 claims description 3
- 239000002775 capsule Substances 0.000 claims description 3
- 238000007598 dipping method Methods 0.000 claims description 3
- 238000000605 extraction Methods 0.000 claims description 3
- 239000012535 impurity Substances 0.000 claims description 3
- 230000008569 process Effects 0.000 claims description 3
- 238000010298 pulverizing process Methods 0.000 claims description 3
- 238000002791 soaking Methods 0.000 claims description 3
- 241000038207 Arcangelisia Species 0.000 claims 4
- 241000592346 Ginkgophyta Species 0.000 claims 4
- 241000736026 Sarcandra Species 0.000 claims 4
- 230000000694 effects Effects 0.000 abstract description 19
- 208000024891 symptom Diseases 0.000 abstract description 14
- 208000003251 Pruritus Diseases 0.000 abstract description 11
- 230000001737 promoting effect Effects 0.000 abstract description 8
- 230000007803 itching Effects 0.000 abstract description 5
- 230000001338 necrotic effect Effects 0.000 abstract description 4
- 231100000331 toxic Toxicity 0.000 abstract description 3
- 230000002588 toxic effect Effects 0.000 abstract description 3
- 239000000463 material Substances 0.000 abstract description 2
- WLNBMPZUVDTASE-HXIISURNSA-N (2r,3r,4s,5r)-2-amino-3,4,5,6-tetrahydroxyhexanal;sulfuric acid Chemical compound [O-]S([O-])(=O)=O.O=C[C@H]([NH3+])[C@@H](O)[C@H](O)[C@H](O)CO.O=C[C@H]([NH3+])[C@@H](O)[C@H](O)[C@H](O)CO WLNBMPZUVDTASE-HXIISURNSA-N 0.000 abstract 1
- 241000173529 Aconitum napellus Species 0.000 abstract 1
- 244000291564 Allium cepa Species 0.000 abstract 1
- 235000002732 Allium cepa var. cepa Nutrition 0.000 abstract 1
- 241000218176 Corydalis Species 0.000 abstract 1
- 241000264877 Hippospongia communis Species 0.000 abstract 1
- 241000218229 Humulus japonicus Species 0.000 abstract 1
- 241001412304 Ixeris Species 0.000 abstract 1
- 240000004274 Sarcandra glabra Species 0.000 abstract 1
- 241001533104 Tribulus terrestris Species 0.000 abstract 1
- 244000178289 Verbascum thapsus Species 0.000 abstract 1
- 235000010599 Verbascum thapsus Nutrition 0.000 abstract 1
- 235000013399 edible fruits Nutrition 0.000 abstract 1
- 230000017423 tissue regeneration Effects 0.000 abstract 1
- 231100000419 toxicity Toxicity 0.000 abstract 1
- 230000001988 toxicity Effects 0.000 abstract 1
- 229940126680 traditional chinese medicines Drugs 0.000 abstract 1
- 210000003491 skin Anatomy 0.000 description 14
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 13
- 201000010099 disease Diseases 0.000 description 12
- 239000008280 blood Substances 0.000 description 9
- 210000004369 blood Anatomy 0.000 description 9
- 210000004072 lung Anatomy 0.000 description 9
- 231100000614 poison Toxicity 0.000 description 9
- 206010011224 Cough Diseases 0.000 description 8
- 201000004624 Dermatitis Diseases 0.000 description 8
- 208000006673 asthma Diseases 0.000 description 7
- 239000003440 toxic substance Substances 0.000 description 7
- 235000009508 confectionery Nutrition 0.000 description 6
- 208000001848 dysentery Diseases 0.000 description 6
- 241000411851 herbal medicine Species 0.000 description 6
- 206010040882 skin lesion Diseases 0.000 description 6
- 231100000444 skin lesion Toxicity 0.000 description 6
- 239000010409 thin film Substances 0.000 description 6
- 208000010201 Exanthema Diseases 0.000 description 5
- 241000218628 Ginkgo Species 0.000 description 5
- 208000002193 Pain Diseases 0.000 description 5
- 230000001684 chronic effect Effects 0.000 description 5
- 201000005884 exanthem Diseases 0.000 description 5
- 230000002757 inflammatory effect Effects 0.000 description 5
- 206010037844 rash Diseases 0.000 description 5
- 239000003053 toxin Substances 0.000 description 5
- 231100000765 toxin Toxicity 0.000 description 5
- 208000032843 Hemorrhage Diseases 0.000 description 4
- 206010061218 Inflammation Diseases 0.000 description 4
- 206010030113 Oedema Diseases 0.000 description 4
- 208000004880 Polyuria Diseases 0.000 description 4
- 206010040943 Skin Ulcer Diseases 0.000 description 4
- 208000010668 atopic eczema Diseases 0.000 description 4
- 206010006451 bronchitis Diseases 0.000 description 4
- 230000035619 diuresis Effects 0.000 description 4
- 208000014674 injury Diseases 0.000 description 4
- 210000003734 kidney Anatomy 0.000 description 4
- 208000004396 mastitis Diseases 0.000 description 4
- 235000012054 meals Nutrition 0.000 description 4
- 230000001717 pathogenic effect Effects 0.000 description 4
- 238000012545 processing Methods 0.000 description 4
- 238000011084 recovery Methods 0.000 description 4
- 231100000019 skin ulcer Toxicity 0.000 description 4
- 210000000952 spleen Anatomy 0.000 description 4
- 230000008961 swelling Effects 0.000 description 4
- 201000004647 tinea pedis Diseases 0.000 description 4
- 230000008736 traumatic injury Effects 0.000 description 4
- 206010000087 Abdominal pain upper Diseases 0.000 description 3
- 206010063409 Acarodermatitis Diseases 0.000 description 3
- 206010017553 Furuncle Diseases 0.000 description 3
- 208000000616 Hemoptysis Diseases 0.000 description 3
- 241000447727 Scabies Species 0.000 description 3
- 230000036528 appetite Effects 0.000 description 3
- 235000019789 appetite Nutrition 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 238000003745 diagnosis Methods 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 230000003203 everyday effect Effects 0.000 description 3
- 238000005469 granulation Methods 0.000 description 3
- 230000003179 granulation Effects 0.000 description 3
- 230000035876 healing Effects 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 230000001939 inductive effect Effects 0.000 description 3
- 230000002147 killing effect Effects 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 201000007227 lymph node tuberculosis Diseases 0.000 description 3
- 239000012567 medical material Substances 0.000 description 3
- 244000045947 parasite Species 0.000 description 3
- 206010034754 petechiae Diseases 0.000 description 3
- 208000008128 pulmonary tuberculosis Diseases 0.000 description 3
- 208000005687 scabies Diseases 0.000 description 3
- 208000017520 skin disease Diseases 0.000 description 3
- 238000004659 sterilization and disinfection Methods 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- 210000002700 urine Anatomy 0.000 description 3
- 239000002435 venom Substances 0.000 description 3
- 231100000611 venom Toxicity 0.000 description 3
- 210000001048 venom Anatomy 0.000 description 3
- 208000006820 Arthralgia Diseases 0.000 description 2
- 208000004429 Bacillary Dysentery Diseases 0.000 description 2
- 206010007247 Carbuncle Diseases 0.000 description 2
- 206010007882 Cellulitis Diseases 0.000 description 2
- 206010010741 Conjunctivitis Diseases 0.000 description 2
- 206010048768 Dermatosis Diseases 0.000 description 2
- 208000005577 Gastroenteritis Diseases 0.000 description 2
- 206010017915 Gastroenteritis shigella Diseases 0.000 description 2
- 206010019233 Headaches Diseases 0.000 description 2
- 206010021531 Impetigo Diseases 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- 208000019637 Infantile Diarrhea Diseases 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 206010059013 Nocturnal emission Diseases 0.000 description 2
- 240000007594 Oryza sativa Species 0.000 description 2
- 235000007164 Oryza sativa Nutrition 0.000 description 2
- 206010033733 Papule Diseases 0.000 description 2
- 206010037660 Pyrexia Diseases 0.000 description 2
- 240000005498 Setaria italica Species 0.000 description 2
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 2
- 206010067868 Skin mass Diseases 0.000 description 2
- 206010053476 Traumatic haemorrhage Diseases 0.000 description 2
- 208000025865 Ulcer Diseases 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 230000001139 anti-pruritic effect Effects 0.000 description 2
- 239000003908 antipruritic agent Substances 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 210000000481 breast Anatomy 0.000 description 2
- 230000003778 catagen phase Effects 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 235000013339 cereals Nutrition 0.000 description 2
- 210000000038 chest Anatomy 0.000 description 2
- 208000002925 dental caries Diseases 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 208000002173 dizziness Diseases 0.000 description 2
- 206010013990 dysuria Diseases 0.000 description 2
- 210000002615 epidermis Anatomy 0.000 description 2
- 239000010408 film Substances 0.000 description 2
- 210000002683 foot Anatomy 0.000 description 2
- 210000003128 head Anatomy 0.000 description 2
- 231100000869 headache Toxicity 0.000 description 2
- 230000036737 immune function Effects 0.000 description 2
- 210000000987 immune system Anatomy 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 230000008595 infiltration Effects 0.000 description 2
- 238000001764 infiltration Methods 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 206010022000 influenza Diseases 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 230000003902 lesion Effects 0.000 description 2
- 201000004792 malaria Diseases 0.000 description 2
- 201000008383 nephritis Diseases 0.000 description 2
- 235000002252 panizo Nutrition 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- 239000002574 poison Substances 0.000 description 2
- 230000001185 psoriatic effect Effects 0.000 description 2
- 230000000284 resting effect Effects 0.000 description 2
- 235000009566 rice Nutrition 0.000 description 2
- 201000005404 rubella Diseases 0.000 description 2
- 201000005113 shigellosis Diseases 0.000 description 2
- 229910052709 silver Inorganic materials 0.000 description 2
- 239000004332 silver Substances 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 235000019640 taste Nutrition 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 206010044008 tonsillitis Diseases 0.000 description 2
- 231100000397 ulcer Toxicity 0.000 description 2
- 206010000060 Abdominal distension Diseases 0.000 description 1
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 206010003011 Appendicitis Diseases 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- 241000003910 Baronia <angiosperm> Species 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 206010006326 Breath odour Diseases 0.000 description 1
- 206010006458 Bronchitis chronic Diseases 0.000 description 1
- 208000002177 Cataract Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 208000004232 Enteritis Diseases 0.000 description 1
- 208000008967 Enuresis Diseases 0.000 description 1
- 206010015278 Erythrodermic psoriasis Diseases 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 206010017533 Fungal infection Diseases 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 206010018092 Generalised oedema Diseases 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 206010018612 Gonorrhoea Diseases 0.000 description 1
- 208000023329 Gun shot wound Diseases 0.000 description 1
- 208000032139 Halitosis Diseases 0.000 description 1
- 206010019345 Heat stroke Diseases 0.000 description 1
- 208000007514 Herpes zoster Diseases 0.000 description 1
- 208000003367 Hypopigmentation Diseases 0.000 description 1
- 206010061217 Infestation Diseases 0.000 description 1
- 208000006877 Insect Bites and Stings Diseases 0.000 description 1
- 206010023232 Joint swelling Diseases 0.000 description 1
- 206010024238 Leptospirosis Diseases 0.000 description 1
- 208000019693 Lung disease Diseases 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- 201000005505 Measles Diseases 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- BYBLEWFAAKGYCD-UHFFFAOYSA-N Miconazole Chemical compound ClC1=CC(Cl)=CC=C1COC(C=1C(=CC(Cl)=CC=1)Cl)CN1C=NC=C1 BYBLEWFAAKGYCD-UHFFFAOYSA-N 0.000 description 1
- 208000031888 Mycoses Diseases 0.000 description 1
- 241000237502 Ostreidae Species 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- 201000001263 Psoriatic Arthritis Diseases 0.000 description 1
- 208000036824 Psoriatic arthropathy Diseases 0.000 description 1
- 206010037549 Purpura Diseases 0.000 description 1
- 241001672981 Purpura Species 0.000 description 1
- 206010037596 Pyelonephritis Diseases 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- 206010039793 Seborrhoeic dermatitis Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 208000004078 Snake Bites Diseases 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 201000002014 Suppurative Otitis Media Diseases 0.000 description 1
- 206010053615 Thermal burn Diseases 0.000 description 1
- 206010044302 Tracheitis Diseases 0.000 description 1
- 206010046914 Vaginal infection Diseases 0.000 description 1
- 201000008100 Vaginitis Diseases 0.000 description 1
- 206010047642 Vitiligo Diseases 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 208000005946 Xerostomia Diseases 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 208000019790 abdominal distention Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 201000004484 acute conjunctivitis Diseases 0.000 description 1
- 208000012873 acute gastroenteritis Diseases 0.000 description 1
- 210000005006 adaptive immune system Anatomy 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 208000007451 chronic bronchitis Diseases 0.000 description 1
- 231100000749 chronicity Toxicity 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 201000003146 cystitis Diseases 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 206010013781 dry mouth Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 210000004905 finger nail Anatomy 0.000 description 1
- 238000007667 floating Methods 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 208000001786 gonorrhea Diseases 0.000 description 1
- 210000004013 groin Anatomy 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000002607 hemopoietic effect Effects 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 230000001969 hypertrophic effect Effects 0.000 description 1
- 230000003425 hypopigmentation Effects 0.000 description 1
- 230000008105 immune reaction Effects 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 210000002510 keratinocyte Anatomy 0.000 description 1
- 210000000629 knee joint Anatomy 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 201000011486 lichen planus Diseases 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000002932 luster Substances 0.000 description 1
- 230000001071 malnutrition Effects 0.000 description 1
- 235000000824 malnutrition Nutrition 0.000 description 1
- 229960002509 miconazole Drugs 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 201000009240 nasopharyngitis Diseases 0.000 description 1
- 208000015380 nutritional deficiency disease Diseases 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 235000020636 oyster Nutrition 0.000 description 1
- 239000003973 paint Substances 0.000 description 1
- 230000003071 parasitic effect Effects 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 201000007801 psoriasis 2 Diseases 0.000 description 1
- 230000000306 recurrent effect Effects 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 208000020029 respiratory tract infectious disease Diseases 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- 201000003068 rheumatic fever Diseases 0.000 description 1
- 210000004761 scalp Anatomy 0.000 description 1
- 208000008742 seborrheic dermatitis Diseases 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 239000004575 stone Substances 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 230000002123 temporal effect Effects 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 208000004371 toothache Diseases 0.000 description 1
- 230000000472 traumatic effect Effects 0.000 description 1
- 230000002485 urinary effect Effects 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/16—Ginkgophyta, e.g. Ginkgoaceae (Ginkgo family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/59—Menispermaceae (Moonseed family), e.g. hyperbaena or coralbead
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
- A61K36/638—Ligustrum, e.g. Chinese privet
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/66—Papaveraceae (Poppy family), e.g. bloodroot
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
- A61K36/714—Aconitum (monkshood)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/85—Verbenaceae (Verbena family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8962—Allium, e.g. garden onion, leek, garlic or chives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/53—Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Medical Informatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Insects & Arthropods (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种治疗牛皮癣的中药制剂及制备方法,属中药领域;本发明中药制剂有效成分的原料组成为:剪刀股、银杏、牡荆叶、蜂房、刺蒺藜、葎草、古山龙、羽萼、观音苋、谷芽、小蜡树、肿节风、牛扁、竹叶蕉、紫堇和山韭菜;本发明中药制剂所选药材配伍相宜,符合中医药学和现代医药学理论,并具有清热解毒、祛风止痒、去腐生肌之功效,对治疗牛皮癣具有显著的疗效,且疗程短,见效快,服用方便,治愈后不复发,安全可靠,无任何毒副作用,服药期间可正常工作和生活,奇效实用,标本兼治,值得广泛推广应用。
Description
所属技术领域
本发明涉及中药领域,尤其涉及一种治疗牛皮癣的中药制剂及制备方法。
背景技术
牛皮癣是一种常见的具有特征性皮损的慢性易于复发的炎症性皮肤病。初起为炎性红色丘疹,约粟粒至绿豆大小,以后逐渐扩大或融合成为棕红色斑块,边界清楚,周围有炎性红晕,基底浸润明显,表面覆盖多层干燥的灰白色或银白色鳞屑。轻轻刮除表面鳞屑,逐渐露出一层淡红色发亮的半透明薄膜,称薄膜现象。再刮除薄膜,则出现小出血点,称点状出血现象。白色鳞屑、发亮薄膜和点状出血是诊断牛皮癣的重要特征,称为三联征,牛皮癣皮损从发生到最后消退大致可分为三个时期:进行期、静止期、退行期。
皮疹特点初起为炎性红色丘疹,约粟粒至绿豆大小,以后逐渐扩大或融合成为棕红色斑块,边界清楚,周围有炎性红晕,基底浸润明显,表面覆盖多层干燥的灰白色或银白色鳞屑。轻轻刮除表面鳞屑,逐渐露出一层淡红色发亮的半透明薄膜,称薄膜现象,再刮除薄膜,则出现小出血点,称点状出血现象。白色鳞屑、发亮薄膜和点状出血是诊断银屑病的重要特征,称为三联征。皮损形态:点滴状、钱币状、地图状、环状、带状、泛发性、脂溢性皮炎样、湿疹样、蛎壳状、扁平苔藓样、慢性肥厚性、疣状等。好发部位头皮、四肢伸侧多见,对称分布;指甲和黏膜亦可被侵,少数可见于腋窝及腹股沟等皱襞部,掌跖很少发生。病程慢性病程,反复发作。大部分患者为冬重夏轻,少数患者夏重冬轻。病程一般分三期:进行期,新皮疹不断出现,旧皮疹不断扩大,鳞屑厚,炎症明显,痒感显著,皮肤敏感性增高,可出现同形反应;静止期,无新疹,旧疹不退;退行期,炎症消退,鳞屑减少,皮疹缩小变平,周围出现浅色晕,最后遗留暂时性色素减退或沉着。近年的发现表明牛皮癣作为一种多基因疾病,涉及免疫系统和角质形成细胞异常的一些基因多态性均可以是牛皮癣的发病原因,现在认为表皮也是天然免疫反应中的一个重要活性部分,可以影响适应性免疫系统的活化。因此牛皮癣既可以适应性免疫系统异常造成,也可以由表皮细胞的天然免疫功能异常引起。
牛皮癣是皮肤疾病的一大顽疾,西医治疗大多只是以消除皮肤损害为目的,虽见效快,但只有暂时效果,且副作用大,治愈后易复发,价格昂贵,而中医治疗主要是因为其病因、病理目前仍不十分清楚,致使病情慢性化,难以治愈,且易复发。
发明内容
本发明提供了一种治疗牛皮癣的中药制剂及制备方法;本发明中药制剂所选药材配伍相宜,符合中医药学和现代医药学理论,并具有清热解毒、祛风止痒、去腐生肌之功效,对治疗牛皮癣具有显著的疗效,且疗程短,见效快,服用方便,治愈后不复发,安全可靠,无任何毒副作用,服药期间可正常工作和生活,奇效实用,标本兼治,值得广泛推广应用。
为实现上述目的,本发明的技术方案实施如下:
一种治疗牛皮癣的中药制剂,制成所述中药制剂有效成分的原料组成及重量份数为:
制成所述中药制剂有效成分的原料组成及重量份数为:
制成所述中药制剂有效成分的原料组成及重量份数为:
制成所述中药制剂有效成分的原料组成及重量份数为:
一种治疗牛皮癣的中药制剂的制备方法,包括以下工艺步骤:
(1)将剪刀股、银杏、刺蒺藜、古山龙、羽萼、观音苋、小蜡树、牛扁、紫堇和山韭菜洗净,放入容器内,加入8~10倍量的蒸馏水,浸泡5~6小时后,煮沸3~4小时,提取;再次加入6~8倍量蒸馏水,煮沸2~3小时,提取;最后,加入4~6倍量蒸馏水,加热煮沸1~2小时,提取;合并三次提取液,过滤,得滤液,浓缩成60℃下相对密度为1.10~1.15的稠膏,备用;
(2)将牡荆叶和葎草洗净,切碎,放入容器内,绞汁,滤杂质,留汁液备用;
(3)将蜂房、谷芽和竹叶蕉放入容器内,进行粉碎处理,研末,得到过180目的细粉,备用;
(4)将肿节风洗净,浸入2倍量的50%的乙醇溶液浸泡1~2小时,加热提取3小时,回收乙醇,滤过,得滤液,浓缩为65℃下相对密度为1.13~1.17的稠膏,备用;
(5)将上述步骤(1)~(4)所制得的稠膏、汁液以及细粉制成胶囊,即得所述的治疗牛皮癣的中药制剂。
本发明所用中药的药性如下:
剪刀股:味苦,性寒;归胃、肚、肾经。清热凉血,利尿消肿。用于肺热咳嗽,喉痛,口腔溃疡,急性结膜炎,阑尾炎,水肿,小便不利;外用治乳腺炎,疮疖肿毒,皮肤瘙痒。广州空军《常用中草药手册》载:“解热毒,消痈肿,凉血,利尿。”
银杏:味甘、苦涩,性平;入肺、肾经。敛肺气,定喘嗽,止带浊,缩小便,消毒杀虫。主治哮喘,痰嗽,梦遗,白带,白浊,小儿腹泻,虫积,肠风脏毒,淋病,小便频数,以及疥癣、漆疮、白瘤风等病症。《本经逢源》载:“白果有降痰、清毒、杀虫之功能,可治疗“疮疥疽瘤、乳痈溃烂、牙齿虫龋、小儿腹泻、赤白带下、慢性淋浊、遗精遗尿等症。”经实验证明银杏有抑菌和杀菌作用,可用于治疗呼吸道感染性疾病。银杏水浸剂对各种真菌有不同程度的抑制作用,可止痒疗癣。
牡荆叶:味辛、苦,性平;归肺经。解表化湿,祛痰平喘,除湿解毒,祛风解表,杀虫止痛。主治伤风感冒,咳嗽哮喘,胃痛,腹痛,暑湿泻痢,脚气肿胀,风疹瘙痒,脚癣,乳痈肿痛,蛇虫咬伤。《名医别录》载:“主久痢,霍乱转筋,血淋,下部疮,脚气肿满。”
蜂房:味甘,性平,归胃经。去腐生肌、消炎止痛,抗过敏。适用龋齿牙痛,疮疡肿毒,乳痈,瘰疬,皮肤顽癣,鹅掌风,过敏性体质。《云南思茅中草药选》载:“舒筋活络,法风湿,利尿。治风湿性关节炎,腰膝湿痹,肾炎水肿。”现代医学研究证实,蜂巢制剂有促进机体细胞免疫功能的作用。
刺蒺藜:苦辛,温;入肝、肺经。散风明目,下气行血。主头痛,眩晕,胸胁胀痛,乳房胀痛,乳闭不通,经闭,目赤翳障,风疹瘙痒,白癜风,疮疽,瘰疬。《别录》载:“主身体风痒,头痛、咳逆伤肺,肺痿,止烦、下气;小儿头疮,痈肿阴癀,可作摩粉。”
葎草:味甘、苦,性寒;归肺、肾经。清热解毒,利尿消肿。用于肺结核潮热,肠胃炎,痢疾,感冒发热,小便不利,肾盂肾炎,急性肾炎,膀胱炎,泌尿系结石;外用治痈疖肿毒,湿疹,毒蛇咬伤。《安徽药材》载:“治失眠,洗痔疮。”
古山龙:味苦,性寒;归心、肺、大肠经。清热利湿,解毒止痛。用于预防流行性感冒、钩端螺旋体病,治急性胃肠炎,细菌性痢疾,扁桃体炎,支气管炎,疟疾;外用治眼结膜炎,皮肤湿疹,脓疱疮,阴道炎。广州部队《常用中草药手册》载:“清热解毒。治肠炎,菌痢,扁桃体炎,支气管炎,疖肿,疟疾,皮炎,湿疹,脓疱疮,脚癣感染。”
羽萼:味辛,性平。消炎止血。主治鼻衄,咳血。外用治外伤出血,皮炎,癣。
观音苋:味辛,甘,性凉。清热凉血,解毒消肿。主咳血,崩漏,外伤出血,痛经,痢疾,疮疡肿毒,跌打损伤,溃疡久不收敛。《福建中草药》载:“生血止血,清热消肿。”
谷芽:味甘,性平;归脾、胃经。消食和中,健脾开胃。用于食积不消,腹胀口臭,脾胃虚弱,不饥食少,炒谷芽偏于消食,用于不饥食少,焦谷芽善化积滞,用于积滞不消。《本草经疏》载:“蘖米即稻蘖也,具生化之性,故为消食健脾、开胃和中之要药,脾胃和则中自瘟,气自下,热自除也。”
小蜡树:味苦,性寒。清热解毒,抑菌杀菌,消肿止痛,祛腐生肌,用于急性黄疸型传染性肝炎,痢疾,肺热咳嗽;外用治跌打损伤,创伤感染,烧烫伤,疮疡肿毒等外科感染性疾病。
肿节风:味苦、辛,性平;归心、肝经。清热凉血,活血消斑,祛风通络。用于血热紫斑、紫癜,风湿痹痛,跌打损伤。
牛扁:味苦,性温。祛风止痛,止咳平喘,化痰。用于慢性支气管炎,腰腿痛,关节肿痛;外用治疥癣,淋巴结结核。
竹叶蕉:味淡,性凉;归肺经。清热解毒,止咳定喘,消炎杀菌。主治肺结核,气管炎,支气管炎,哮喘,高热,小儿麻疹,合并肺炎,感冒,发热,各种皮肤病。
紫堇:味苦、涩,性凉;归肺、肾、脾经。清热解毒,杀虫止痒。用于中暑头痛,腹痛,尿桶,肺结核咯血;外用治化脓性中耳炎,脱肛,疮疡肿毒,蛇咬伤。《陕西中草药》载:“清热解毒,止痒,收敛,固精。治疮毒,顽癣,秃疮,带状疱疹,蛇咬伤,脱肛,遗精。”药理实验表明,紫堇25%煎液试管内对金黄色葡萄球菌有显着的抑制作用,对大肠杆菌、绿脓杆菌次之。
山韭菜:味辛、甘,性平;归肝、脾经。活血散瘀,祛风止痒。主跌打损伤,枪伤,荨麻疹,牛皮癣,漆疮。
本发明与现有技术相比,具有以下有益效果:
本发明中药制剂所选药材配伍相宜,符合中医药学和现代医药学理论,并具有清热解毒、祛风止痒、去腐生肌之功效,对治疗牛皮癣具有显著的疗效,且疗程短,见效快,服用方便,治愈后不复发,安全可靠,无任何毒副作用,服药期间可正常工作和生活,奇效实用,标本兼治,值得广泛推广应用。
具体实施方式
下面结合具体实施例对本发明做进一步阐述。
实施例1
本发明中药制剂有效成分的原料组成及重量为:
一种治疗牛皮癣的中药制剂的制备方法,包括以下工艺步骤:
(1)将剪刀股、银杏、刺蒺藜、古山龙、羽萼、观音苋、小蜡树、牛扁、紫堇和山韭菜洗净,放入容器内,加入8~10倍量的蒸馏水,浸泡5~6小时后,煮沸3~4小时,提取;再次加入6~8倍量蒸馏水,煮沸2~3小时,提取;最后,加入4~6倍量蒸馏水,加热煮沸1~2小时,提取;合并三次提取液,过滤,得滤液,浓缩成60℃下相对密度为1.10~1.15的稠膏,备用;
(2)将牡荆叶和葎草洗净,切碎,放入容器内,绞汁,滤杂质,留汁液备用;
(3)将蜂房、谷芽和竹叶蕉放入容器内,进行粉碎处理,研末,得到过180目的细粉,备用;
(4)将肿节风洗净,浸入2倍量的50%的乙醇溶液浸泡1~2小时,加热提取3小时,回收乙醇,滤过,得滤液,浓缩为65℃下相对密度为1.13~1.17的稠膏,备用;
(5)将上述步骤(1)~(4)所制得的稠膏、汁液以及细粉制成胶囊,即得所述的治疗牛皮癣的中药制剂。
用法用量:口服即可,每日2次,早晚各1次,每次2粒(每粒0.5g),饭后温开水送服;16天为1个疗程,1~4个疗程即可痊愈,病情严重者遵医嘱酌增用量。
实施例2
本发明中药制剂有效成分的原料组成及重量为:
本实施例的中药制剂制备方法工艺步骤及用法用量与实施例1相同。
实施例3
本发明中药制剂有效成分的原料组成及重量为:
本实施例的中药制剂制备方法工艺步骤及用法用量与实施例1相同。
实施例4
本发明中药制剂有效成分的原料组成及重量为:
本实施例的中药制剂制备方法工艺步骤及用法用量与实施例1相同。
实施例5
本发明中药制剂有效成分的原料组成及重量为:
本实施例的中药制剂制备方法工艺步骤及用法用量与实施例1相同。
临床资料:
1、病例选择:
作为治疗牛皮癣的中药制剂,选择确诊的牛皮癣患者508例临床观察,病人随机分成治疗组和对照组两组,治疗组254例,其中男性127例,女性127例,年龄14~69岁,平均年龄41.5岁,平均病程5年;对照组254例,其中男性127例,女性127例,年龄15~68岁,平均年龄41.5岁,平均病程5年。
治疗组和对照组两组病例的病程、症状轻重程度基本一致,无显著差异,具有可比性。
2、药物选择:
治疗组服用本发明中药制剂,口服即可,每日2次,早晚各1次,每次2粒(每粒0.5g),饭后温开水送服;16天为1个疗程,1~4个疗程即可痊愈,病情严重者遵医嘱酌增用量。
对照组使用咪康唑软膏,每日2次,敷药膏于患处,用手指涂擦,使药物全部渗入皮肤。待患处损害全部消失后(通常需2-5周),应继续用药一周,以防复发。
3、疗效判定:
(1)治愈:皮肤瘙痒症状全部消失,皮肤恢复正常。
(2)显效:上述症状明显减轻,皮肤明显好转。
(3)有效:上述症状有所减轻,皮肤有所好转。
(4)无效:通过治疗后上述症状无减轻或加重。
4、结果:
选用本发明中药制剂的治疗组中,治愈167例,显效52例,有效31例,无效4例,治愈率65.7%,总有效率98.4%。
对照组中治愈154例,显效39例,有效18例,无效43例,治愈率60.6%,总有效率83.1%。
以上结果显示,治疗组的治愈率和总有效率明显高于对照组。
典型病例举例:
1、熊某,女,20岁,湖北荆州人。患者患牛皮癣2年余,曾经服用几种药物治疗,未见任何好转反而病情加重,经医生推荐服用本发明中药制剂治疗,服用1个疗程后,症状明显减轻,服用3个疗程后,症状全部消失,未有遗留脱色斑,皮肤光滑如初,痊愈,1年后电话回访无复发。
2、邹某,男,34岁,湖南衡阳人。患者皮损严重,呈地图样,银屑重叠,瘙痒难忍,去医院就诊,确诊为牛皮癣,使用药物治疗,治疗效果一般,经朋友介绍服用本发明中药制剂治疗,服用1个疗程后,瘙痒感明显减轻,银屑脱落,皮损部位色泽变淡,继续服用2个疗程后,瘙痒感消失,皮损全部消失,皮肤恢复正常,痊愈,半年后随访无复发。
3、廖某,男,29岁,四川广安人。患者患牛皮癣3年余,使用多种药物治疗,未见明显好转,后来我院就诊,服用本发明中药制剂治疗,服用1个疗程后,症状有所好转,服用2个疗程后,症状全部消失,皮肤光滑如初,痊愈,1年后随访无复发。
4、姚某,女,45岁,广东东莞人。患者患牛皮癣4年余,去医院就诊,用过多种药物治疗,未见好转,经医生建议给予本发明中药制剂治疗,服用1个疗程后,症状有所减轻,继续服用2个疗程后,症状消失,痊愈,半年后随访无复发。
5、石某,男,51岁,安徽安庆人。患者小腿覆有鳞斑红屑性皮疹,属关节型银屑病,皮损境界清楚,曾到多家医院诊治,未见任何好转,经朋友介绍服用本发明中药制剂1个疗程后,症状有所好转,服用3个疗程后,症状全部消失,皮肤恢复正常。
6、谭某,女,60岁,江苏盐城人。患者患牛皮癣2年,曾用多种药物治疗,治疗效果不佳,全身泛发斑块状红色皮疹,表面浮有较薄之白色鳞屑,易于剥落,基底部呈鲜红色而呈小出血点,并伴有剧烈痒感,口干溲赤,诊断为红皮病型牛皮癣,医生给予本发明中药制剂治疗,服用2个疗程后,上述症状有所缓解,服用3个疗程后,症状消失,痊愈,皮肤恢复如初。
Claims (5)
1.一种治疗牛皮癣的中药制剂,其特征在于:制成所述中药制剂有效成分的原料组成及重量份数为:
剪刀股47~65份 银杏46~64份 牡荆叶46~64份 蜂房45~63份
刺蒺藜43~62份 葎草44~62份 古山龙43~61份 羽萼42~60份
观音苋42~60份 谷芽41~59份 小蜡树41~59份 肿节风39~57份
牛扁37~55份 竹叶蕉36~54份 紫堇36~54份 山韭菜34~52份。
2.根据权利要求1所述的一种治疗牛皮癣的中药制剂,其特征在于:制成所述中药制剂有效成分的原料组成及重量份数为:
剪刀股50~62份 银杏49~61份 牡荆叶49~61份 蜂房48~60份
刺蒺藜47~59份 葎草47~59份 古山龙46~58份 羽萼45~57份
观音苋45~57份 谷芽44~56份 小蜡树44~56份 肿节风42~54份
牛扁40~52份 竹叶蕉39~51份 紫堇39~51份 山韭菜37~49份。
3.根据权利要求1所述的一种治疗牛皮癣的中药制剂,其特征在于:制成所述中药制剂有效成分的原料组成及重量份数为:
剪刀股53~59份 银杏52~58份 牡荆叶52~58份 蜂房51~57份
刺蒺藜50~56份 葎草50~56份 古山龙49~55份 羽萼48~54份
观音苋48~54份 谷芽47~53份 小蜡树47~53份 肿节风45~51份
牛扁43~49份 竹叶蕉42~48份 紫堇42~48份 山韭菜40~46份。
4.根据权利要求1所述的一种治疗牛皮癣的中药制剂,其特征在于:制成所述中药制剂有效成分的原料组成及重量份数为:
剪刀股56份 银杏55份 牡荆叶55份 蜂房54份
刺蒺藜53份 葎草53份 古山龙52份 羽萼51份
观音苋51份 谷芽50份 小蜡树50份 肿节风48份
牛扁46份 竹叶蕉45份 紫堇45份 山韭菜43份。
5.一种如权利要求1~4任一项所述治疗牛皮癣的中药制剂的制备方法,其特征在于:包括以下工艺步骤:
(1)将剪刀股、银杏、刺蒺藜、古山龙、羽萼、观音苋、小蜡树、牛扁、紫堇和山韭菜洗净,放入容器内,加入8~10倍量的蒸馏水,浸泡5~6小时后,煮沸3~4小时,提取;再次加入6~8倍量蒸馏水,煮沸2~3小时,提取;最后,加入4~6倍量蒸馏水,加热煮沸1~2小时,提取;合并三次提取液,过滤,得滤液,浓缩成60℃下相对密度为1.10~1.15的稠膏,备用;
(2)将牡荆叶和葎草洗净,切碎,放入容器内,绞汁,滤杂质,留汁液备用;
(3)将蜂房、谷芽和竹叶蕉放入容器内,进行粉碎处理,研末,得到过180目的细粉,备用;
(4)将肿节风洗净,浸入2倍量的50%的乙醇溶液浸泡1~2小时,加热提取3小时,回收乙醇,滤过,得滤液,浓缩为65℃下相对密度为1.13~1.17的稠膏,备用;
(5)将上述步骤(1)~(4)所制得的稠膏、汁液以及细粉制成胶囊,即得所述的治疗牛皮癣的中药制剂。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610621975.5A CN105963575A (zh) | 2016-07-30 | 2016-07-30 | 一种治疗牛皮癣的中药制剂及制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610621975.5A CN105963575A (zh) | 2016-07-30 | 2016-07-30 | 一种治疗牛皮癣的中药制剂及制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN105963575A true CN105963575A (zh) | 2016-09-28 |
Family
ID=56951281
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610621975.5A Withdrawn CN105963575A (zh) | 2016-07-30 | 2016-07-30 | 一种治疗牛皮癣的中药制剂及制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105963575A (zh) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101897871A (zh) * | 2010-07-20 | 2010-12-01 | 谭振国 | 治疗牛皮癣的中药 |
CN103860843A (zh) * | 2014-03-19 | 2014-06-18 | 刘力 | 一种治疗牛皮癣的中药药膏及制备方法 |
CN104524212A (zh) * | 2014-12-26 | 2015-04-22 | 尚伟 | 一种治疗银屑病的中药 |
-
2016
- 2016-07-30 CN CN201610621975.5A patent/CN105963575A/zh not_active Withdrawn
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101897871A (zh) * | 2010-07-20 | 2010-12-01 | 谭振国 | 治疗牛皮癣的中药 |
CN103860843A (zh) * | 2014-03-19 | 2014-06-18 | 刘力 | 一种治疗牛皮癣的中药药膏及制备方法 |
CN104524212A (zh) * | 2014-12-26 | 2015-04-22 | 尚伟 | 一种治疗银屑病的中药 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103520607B (zh) | 一种治疗胃炎的中药制剂 | |
CN105477129A (zh) | 一种应用于牛皮癣的外用膏药及制备方法 | |
CN103638316B (zh) | 一种治疗皮炎的中药制剂 | |
CN103495085B (zh) | 一种治疗放射性皮炎的中药制剂 | |
CN103340939B (zh) | 一种治疗产妇妇科疾病的中药制剂及制备方法 | |
CN104383384A (zh) | 一种治疗手足癣的中药洗液 | |
CN103893610B (zh) | 一种治疗手足癣的中药药膏及制备方法 | |
CN104274662A (zh) | 痒必治 | |
CN105963575A (zh) | 一种治疗牛皮癣的中药制剂及制备方法 | |
CN104971312A (zh) | 一种专治牛皮癣的外用药物 | |
CN103690799A (zh) | 一种治疗脑梗塞的中药制剂 | |
CN103721028B (zh) | 一种治疗心绞痛的药物及制备方法 | |
CN103800890B (zh) | 一种治疗月经失调的药物及制备方法 | |
CN107617071A (zh) | 一种用于治疗骨结核的胶囊及制备方法 | |
CN105106590A (zh) | 一种用于治疗过敏性鼻炎的药物 | |
CN105597068A (zh) | 一种用于治疗过敏性鼻炎的中药制剂及制备方法 | |
CN105168805A (zh) | 一种用于阑尾炎术后刀口愈合的外用药膏及制备方法 | |
CN105617103A (zh) | 一种用于治疗盆腔炎的护理清洗药液及制备方法 | |
CN104922595A (zh) | 一种用于带状疱疹的中药制剂及其制备方法 | |
CN104435862A (zh) | 一种治疗神经性皮炎的中药药膏及制备方法 | |
CN103977296A (zh) | 一种治疗尿道炎的中药口服液及制备方法 | |
CN104758830A (zh) | 一种治疗骨病及皮肤损伤的中药组合物及其制备方法 | |
CN103735847A (zh) | 一种治疗湿疹的药物及制备方法 | |
CN104027781A (zh) | 一种治疗冻疮的中药组合物 | |
CN104208380A (zh) | 一种用于治疗败血症的胶囊及制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WW01 | Invention patent application withdrawn after publication | ||
WW01 | Invention patent application withdrawn after publication |
Application publication date: 20160928 |